CAMP

CAMP4 THERAPEUTICS CORPORATION

CalAmp Corp provides wireless communications solutions applications to customers. Its business activities are organized into its Wireless DataCom and Satellite business segments.

CAMP4 THERAPEUTICS CORPORATION (CAMP) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Momentum (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
C+
Factor Score 2.7 / 5.0
Growth
B-
Factor Score 3.1 / 5.0
Profitability
C+
Factor Score 2.5 / 5.0
Momentum
C-
Factor Score 1.9 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -4.8
EV / EBITDA -2.4
Rev Growth YoY 138.9%
Gross Margin 0.0%
Price Return 3M -21.2%
Price Return 12M -9.6%
Catalyst Signal 0.00
Market Cap $242.2M
TTM Revenue $5.3M
Price / Sales 45.5
ROE -146.1%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C+ (2.7) B- (3.1) C+ (2.5) C- (1.9) C+ (2.6) C+ (2.6)
2026-11-10 C+ (2.6) B- (2.9) C+ (2.5) C+ (2.8) C+ (2.6) C+ (2.7)
2026-11-03 C+ (2.7) C- (2.1) C- (2.0) C+ (2.8) C+ (2.7) C (2.5)
2026-10-27 C+ (2.7) C- (2.1) C- (2.0) C+ (2.6) C+ (2.6) C (2.4)
2026-10-20 C+ (2.7) C- (2.1) C- (2.0) B- (2.9) C+ (2.6) C (2.5)
Page 1 of 7